NCT03354884View on ClinicalTrials.gov

caBozantinib in cOllectiNg ductS Renal Cell cArcInoma

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

November 19, 2020

Study Completion Date

November 19, 2020

Conditions
Collecting Duct Carcinoma (Kidney)
Interventions
DRUG

cabozantinib

cabozantinib 60 mg orally once daily

Trial Locations (1)

20133

Giuseppe Procopio, Milan

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT03354884 - caBozantinib in cOllectiNg ductS Renal Cell cArcInoma | Biotech Hunter | Biotech Hunter